Bipartisan trio of senators ask FTC to look at PBMs and tactics to keep insulin prices high
Just this week, the Senate voted 51-50 along party lines (with tie breaker from VP Kamala Harris) to make President Biden appointee Alvaro Bedoya the deciding vote on a split 2-2 Federal Trade Commission. And now that it is no longer split, a group of senators wants the commission to actually move forward on investigating pharmacy benefit managers.
Republican senators Chuck Grassley (IA) and Mike Braun (IN), alongside Democrat senator Ron Wyden (OR), submitted a letter to FTC chair Lina Khan earlier this week, after the commissioners remained deadlocked in a 2-2 vote in February to formally look into anti-competitive practices at the hands of PBMs.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.